These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 15355691)

  • 1. [The expression of CD133 in acute leukemia and its clinical significance].
    Zhou Y; Meng HX; Yu Z; Li Q; Wang YF; Mai YJ; Han JL; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):401-4. PubMed ID: 15355691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The expression and clinical significance of early differentiation antigens in acute leukemia].
    Zhou Y; Li Q; Meng HX; Wang YF; Yu Z; Qiu LG
    Zhonghua Nei Ke Za Zhi; 2005 Jan; 44(1):46-9. PubMed ID: 15769398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping.
    Wuchter C; Ratei R; Spahn G; Schoch C; Harbott J; Schnittger S; Haferlach T; Creutzig U; Sperling C; Karawajew L; Ludwig WD
    Haematologica; 2001 Feb; 86(2):154-61. PubMed ID: 11224484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of CD133 in bone marrow cells of patients with leukemia and myelodysplastic syndrome].
    Wang W; Wang HY; Zhao HX; Cui ZG; Li GL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):470-3. PubMed ID: 17605847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AC133 antigen as a prognostic factor in acute leukemia.
    Lee ST; Jang JH; Min YH; Hahn JS; Ko YW
    Leuk Res; 2001 Sep; 25(9):757-67. PubMed ID: 11489469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD133 in acute leukemia.
    Tolba FM; Foda ME; Kamal HM; Elshabrawy DA
    Med Oncol; 2013 Jun; 30(2):527. PubMed ID: 23532815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD133-2 (AC141) expression analysis in acute leukemia immunophenotyping in correlation to CD34 and P-glycoprotein.
    Guenova M; Balatzenko G
    Hematology; 2008 Jun; 13(3):137-41. PubMed ID: 18702870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patients.
    Feller N; van der Pol MA; Waaijman T; Weijers GW; Westra G; Ossenkoppele GJ; Schuurhuis GJ
    Clin Cancer Res; 2005 Jul; 11(13):4793-801. PubMed ID: 16000576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of two subtype molecules of CD133 in childhood with B linage acute lymphoblastic leukemia and its clinical significance].
    Zhao WL; Nie SS; Xu YY; Zhang YL; Guo DD; Pan J; Wang JM; Zhang XG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):536-40. PubMed ID: 22739150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
    Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
    Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunophenotypic features in 143 cases of acute promyelocytic leukemia].
    Sun HM; Qian SX; Wu YJ; Qiao C; Hong M; Fan L; Yang H; Zhang JF; Zhang SJ; Wu HX; Qiu HX; Lu H; Xu W; Sheng RL; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):176-9. PubMed ID: 19236773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive and negative predictive values of HLA-DR and CD34 in the diagnosis of acute promyelocytic leukemia and other types of acute myeloid leukemia with recurrent chromosomal translocations.
    Promsuwicha O; Auewarakul CU
    Asian Pac J Allergy Immunol; 2009 Dec; 27(4):209-16. PubMed ID: 20232575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional profiling reflects shared and unique characters for CD34+ and CD133+ cells.
    Hemmoranta H; Hautaniemi S; Niemi J; Nicorici D; Laine J; Yli-Harja O; Partanen J; Jaatinen T
    Stem Cells Dev; 2006 Dec; 15(6):839-51. PubMed ID: 17253947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD133 (AC133) expression on AML cells and progenitors.
    Vercauteren SM; Sutherland HJ
    Cytotherapy; 2001; 3(6):449-59. PubMed ID: 11953029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of AC133 vs. CD34 in acute childhood leukemias].
    Ebener U; Brinkmann A; Zotova V; Niegemann E; Wehner S
    Klin Padiatr; 2000; 212(3):90-8. PubMed ID: 10916777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunophenotype of acute leukemia and its clinical significance].
    Zhu H; Niu T; Meng W; Xu C; Lei S
    Hua Xi Yi Ke Da Xue Xue Bao; 2002 Jan; 33(1):118-20. PubMed ID: 12599447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progenitor marker CD133 mRNA is elevated in peripheral blood of cancer patients with bone metastases.
    Mehra N; Penning M; Maas J; Beerepoot LV; van Daal N; van Gils CH; Giles RH; Voest EE
    Clin Cancer Res; 2006 Aug; 12(16):4859-66. PubMed ID: 16914572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of peripheral blood CD133 mRNA in identifying metastasis and in predicting recurrence of patients with clear cell renal cell carcinoma.
    Feng G; Jiang F; Pan C; Pu C; Huang H; Li G
    Urol Oncol; 2014 Jan; 32(1):44.e9-14. PubMed ID: 24054866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinical significance of real-time fluorescence PCR quantification of hepatocyte growth factor mRNA expression in acute leukemia].
    Cen D; Lü JX; Pei RZ; Tu ZG; Yu XL; Wen YA
    Zhonghua Nei Ke Za Zhi; 2008 May; 47(5):401-4. PubMed ID: 18953951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.